Key Takeaway: While compounded semaglutide is not FDA-approved, it is a legal and recognized way for providers to treat patients using ingredients from regulated, inspected pharmacies, especially during periods of national drug shortages
10.1038/oncsis.2017.83 83
Metabolic adaptations occur over weeks, not days
LegitScript certified, HIPAA compliant, with its own independent medical team that prescribes at their discretion
Patients typically begin using GLP with a lower dose that is gradually increased over several weeks, which helps minimize the onset of any potential side effects and helps the body to adjust to the medication
This lack of approval means there are no standardized dosing guidelines, and the long-term effects remain largely unstudied in clinical settings